New Drug for Multiple Sclerosis
603982
The US Food and Drug Administration has approved Tysabri (natalizumab) as a new treatment for multiple sclerosis. The incurable nervous system disease affects about 350,000 Americans.
327757
LONDON - Drugs given to patients with multiple sclerosis can reduce brain tissue loss and slow down the progression of the illness, scientists said on Friday.
589264
Panacos releases more clinical trial results for an exciting drug.
281372
Better test results for Elan Corp's key  Antegren drug lifted the Irish company's shares more than 10  percent as analysts said the data improved its chances of  becoming the leading multiple sclerosis treatment.
564004
Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.
18314
WASHINGTON -- The government has approved a drug that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
395555
Better test results for Elan Corp&#39;s key Antegren drug lifted the Irish company&#39;s shares more than 10 percent as analysts said the data improved its chances of becoming the leading multiple sclerosis treatment.
729928
Two infusions of the cancer drug Rituxan  given two weeks apart slowed the progression of multiple  sclerosis for nearly a year, researchers reported on Wednesday.
766116
LONDON (CBS.MW) -- Elan (UK:ELA) (ELN) and partner Biogen (BIIB) said the FDA has approved new drug Tysabri to treat relapsing forms of multiple sclerosis.
103036
A trial of a new type of schizophrenia drug shows promise in patients.
64073
Tysabri, a treatment for multiple sclerosis, received regulatory approval on Monday for use among patients with Crohnâs disease.
18405
The Food and Drug Administration on Tuesday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
128455
MONDAY, Nov. 8 (HealthDayNews) -- Memory problems that prevent multiple sclerosis sufferers from doing their jobs are extremely troublesome and disheartening, say doctors, but a drug geared for Alzheimer's patients may offer some help.
757229
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis. The companies said they plan on reporting phase 2 results Oct. 14. After phase 3, they hope to seek US regulatory approval in 2011 to market the drug, also known as alemtuzumab, to ...
298087
An abundance of vitamin D seems to help prevent multiple sclerosis, according to a study in more than 7 million people that offers some of the strongest evidence yet of the power of the "sunshine vitamin" against MS.
59092
The FDA, which has been under criticism for its lengthy approval process, this week approved two new drugs for multiple sclerosis and cancer treatment.